344 related articles for article (PubMed ID: 12899614)
21. SDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domain.
Babb R; Bowen BR
Biochem J; 2003 Mar; 370(Pt 2):719-27. PubMed ID: 12444922
[TBL] [Abstract][Full Text] [Related]
22. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
23. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.
Shi Y; Hon M; Evans RM
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2613-8. PubMed ID: 11867749
[TBL] [Abstract][Full Text] [Related]
24. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
25. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
Shiraki T; Kodama TS; Jingami H; Kamiya N
Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
[TBL] [Abstract][Full Text] [Related]
26. Synthetic retinoids dissociate coactivator binding from corepressor release.
Zechel C
J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma.
Agostini M; Gurnell M; Savage DB; Wood EM; Smith AG; Rajanayagam O; Garnes KT; Levinson SH; Xu HE; Schwabe JW; Willson TM; O'Rahilly S; Chatterjee VK
Endocrinology; 2004 Apr; 145(4):1527-38. PubMed ID: 14657011
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
29. Activity and subcellular compartmentalization of peroxisome proliferator-activated receptor alpha are altered by the centrosome-associated protein CAP350.
Patel H; Truant R; Rachubinski RA; Capone JP
J Cell Sci; 2005 Jan; 118(Pt 1):175-86. PubMed ID: 15615782
[TBL] [Abstract][Full Text] [Related]
30. Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligands.
Kainuma M; Kasuga J; Hosoda S; Wakabayashi K; Tanatani A; Nagasawa K; Miyachi H; Makishima M; Hashimoto Y
Bioorg Med Chem Lett; 2006 Jun; 16(12):3213-8. PubMed ID: 16617018
[TBL] [Abstract][Full Text] [Related]
31. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.
Ebdrup S; Pettersson I; Rasmussen HB; Deussen HJ; Frost Jensen A; Mortensen SB; Fleckner J; Pridal L; Nygaard L; Sauerberg P
J Med Chem; 2003 Apr; 46(8):1306-17. PubMed ID: 12672231
[TBL] [Abstract][Full Text] [Related]
33. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
Cobb JE; Blanchard SG; Boswell EG; Brown KK; Charifson PS; Cooper JP; Collins JL; Dezube M; Henke BR; Hull-Ryde EA; Lake DH; Lenhard JM; Oliver W; Oplinger J; Pentti M; Parks DJ; Plunket KD; Tong WQ
J Med Chem; 1998 Dec; 41(25):5055-69. PubMed ID: 9836622
[TBL] [Abstract][Full Text] [Related]
34. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
Stevens A; Garside H; Berry A; Waters C; White A; Ray D
Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
[TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
Burendahl S; Treuter E; Nilsson L
Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
[TBL] [Abstract][Full Text] [Related]
36. [Androgen receptor and SMRT].
Liao GQ; Tang HH; Lü XS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):157-62. PubMed ID: 16145900
[TBL] [Abstract][Full Text] [Related]
37. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
Germain P; Iyer J; Zechel C; Gronemeyer H
Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
[TBL] [Abstract][Full Text] [Related]
38. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis.
Ge K; Guermah M; Yuan CX; Ito M; Wallberg AE; Spiegelman BM; Roeder RG
Nature; 2002 May; 417(6888):563-7. PubMed ID: 12037571
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype.
Kuwabara N; Oyama T; Tomioka D; Ohashi M; Yanagisawa J; Shimizu T; Miyachi H
J Med Chem; 2012 Jan; 55(2):893-902. PubMed ID: 22185225
[TBL] [Abstract][Full Text] [Related]
40. Development of a homogeneous, fluorescence resonance energy transfer-based in vitro recruitment assay for peroxisome proliferator-activated receptor delta via selection of active LXXLL coactivator peptides.
Drake KA; Zhang JH; Harrison RK; McGeehan GM
Anal Biochem; 2002 May; 304(1):63-9. PubMed ID: 11969190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
